Shu-rong Zheng

Male Breast Carcinoma Metastatic to the Choroid: A Case Report and Opinions of Management

Guilong Guo, Weida Fu, Shu-rong Zheng, 2022, Cancer management and research.

Suppression of MD 2 inhibits breast cancer in vitro and in vivo

G. Guo, Jie Zhou, W. Fu, 2021 .

Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors.

Wei Zhang, G. Guo, Shu-rong Zheng, 2013, Asian Pacific journal of cancer prevention : APJCP.

miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis

Xiaohua Zhang, J. You, Shu-rong Zheng, 2016, Tumor Biology.

Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis

Wei Zhang, Guan-li Huang, Xiao-qu Hu, 2012, Oncology reports.

circGFRA1 affects the sensitivity of triple negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway.

Zhi-hai Zheng, Zhong-tao Zhang, G. Guo, 2021, Journal of biochemistry.

IMP3 promotes TNBC stem cell property through miRNA-34a regulation.

G-L Guo, Shu-rong Zheng, Y. Shen, 2018, European review for medical and pharmacological sciences.

LncRNA PRKCQ‐AS1 regulates paclitaxel resistance in triple‐negative breast cancer cells through miR‐361‐5p/PIK3C3 mediated autophagy

Guilong Guo, Weida Fu, Shu-rong Zheng, 2023, Clinical and experimental pharmacology & physiology.

Primary ectopic substernal thyroid cancer with trachea relapse: a case report and opinions of management

Du-Ping Huang, L. Lv, J. You, 2016, World Journal of Surgical Oncology.